WindRose Health Investors

General contacts

Investor type

Founded

2000

AUM

$3 700 M

Location

New York, New York, United States

Investment Ticket

$10-50 m

Investment Stage

Series B Late Stage (Series C+)

Region of investment

North America Europe

Investor profile last updated: 16 August, 2026

Profile

WindRose Health Investors is a private equity firm based in New York, founded in 1999. The firm specializes in healthcare investments, focusing on businesses that enhance quality and efficiency in the healthcare sector. With a team of 21 professionals, WindRose leverages its expertise to navigate the dynamic healthcare landscape, aiming to capitalize on demographic trends and technological advancements.

The firm invests in a range of sectors including healthcare, wellness, manufacturing, information technology, artificial intelligence, and life sciences. WindRose typically engages in buyout and growth/expansion investments, managing approximately $3 billion in capital. The firm is currently investing from its sixth fund, WindRose Health Investors Fund VI, which has an AUM of $1.4 billion.

Notable portfolio companies include AdvisorWoRx - consulting services, BluHaven Health - clinics/outpatient services, Realo Specialty Care - healthcare services, Certara - regulatory and medical writing, and Tria Health - managed care. These investments reflect WindRose's commitment to supporting innovative solutions in the healthcare industry.

Industry

Manufacturing Longevity / Wellness Life Sciences Healthcare Services Marketing and Advertising Medical Devices HealthTech Media and Entertainment

WindRose Health Investors Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
WindRose Health Investors Fund III	Private Equity (PE)	Healthcare Services Marketing and Advertising Media and Entertainment HealthTech	Series B Late Stage (Series C+)	North America	$5-10 m	$188 M	December 2014
WindRose Health Investors Fund IV	Private Equity (PE)	Healthcare Services Marketing and Advertising Media and Entertainment HealthTech	Series B Late Stage (Series C+)	North America	$5-10 m	$365 M	December 2016
WindRose Health Investors Fund VI	Private Equity (PE)	Healthcare Services Marketing and Advertising Media and Entertainment HealthTech	Series B Late Stage (Series C+)	North America	$5-10 m	$1400 M	July 2023

Contacts

Name

Title

Social Networks

Bren Hall Partner

Partner

h•••@•••

Jonathan Gavras Operating Partner

Operating Partner

g•••@•••

Upgrade to see contacts

ICkLHMwYrnqzWTlO ICkLHMwYrnqzWTlO

ICkLHMwYrnqzWTlO

[email protected]

ICkLHMwYrnqzWTlO ICkLHMwYrnqzWTlO

ICkLHMwYrnqzWTlO

[email protected]

ICkLHMwYrnqzWTlO ICkLHMwYrnqzWTlO

ICkLHMwYrnqzWTlO

[email protected]

Investment-team contacts for WindRose Health Investors — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about WindRose Health Investors

Is WindRose Health Investors a venture capital or private equity firm?

WindRose Health Investors is a private equity firm. It backs companies at Series B and Late Stage (Series C+), writing tickets of $10-50 m.

Where is WindRose Health Investors located?

WindRose Health Investors is located in New York, New York, United States.

When was WindRose Health Investors founded?

WindRose Health Investors was founded in 2000.

What sectors and industries does WindRose Health Investors invest in?

WindRose Health Investors invests in companies and startups in Manufacturing, Longevity / Wellness, Life Sciences, Healthcare Services, Marketing and Advertising, Medical Devices, HealthTech, Media and Entertainment.

What is WindRose Health Investors geographical focus of investments?

WindRose Health Investors invests in companies and startups in North America, Europe.

At what stages of companies and startups does WindRose Health Investors typically invest in?

WindRose Health Investors invests in companies and startups at Series B, Late Stage (Series C+).

What is the usual amount of WindRose Health Investors investment?

WindRose Health Investors usually invests $10-50 m on average.

What is the amount of assets of under management (AUM) for WindRose Health Investors?

WindRose Health Investors has around $3 700m assets under management.

When was WindRose Health Investors last fund created?

WindRose Health Investors last fund was created/launched in 2023-07-12

What are the contacts of WindRose Health Investors?

WindRose Health Investors can be reached through its website windrose.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for WindRose Health Investors — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access WindRose Health Investors data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query WindRose Health Investors directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the WindRose Health Investors profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.